Evidence map›Paper›PMID 39140008›Full record

ArticleRisk management and healthcare policy2024

Dynamics and Efficacy: A Comprehensive Evaluation of the Advanced Dengue Fever Surveillance and Early Warning System in Ningbo City, 2023.

Yanwu Zhang, Buasiyamu Abudunaibi, Yunkang Zhao, Dongliang Zhang, Yanru Chu, Song Lei, Xiaomin Gu, Xuying Lao, Xianhao Wu, Weitao Yao and 2 more

Abstract read
In one paragraph

Article in Risk management and healthcare policy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Forecasting and Early Warning Systems for Dengue Outbreaks: Updated Narrative Review.Revista da Sociedade Brasileira de Medicina Tropical · 2026
    Review
  3. Epidemiology and infection · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yanwu Zhang *Department of Infectious Disease Control and Prevention, Ningbo Prefectural Center for Disease Control and Prevention, Ningbo, Zhejiang Province, People's Republic of China.
Buasiyamu Abudunaibi *State Key Laboratory of Vaccines for Infectious Diseases, Xiang' an Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, Fujian Province, People's Republic of China.
Yunkang ZhaoState Key Laboratory of Vaccines for Infectious Diseases, Xiang' an Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, Fujian Province, People's Republic of China.
Dongliang ZhangDepartment of Infectious Disease Control and Prevention, Ningbo Prefectural Center for Disease Control and Prevention, Ningbo, Zhejiang Province, People's Republic of China.
Yanru ChuDepartment of Infectious Disease Control and Prevention, Ningbo Prefectural Center for Disease Control and Prevention, Ningbo, Zhejiang Province, People's Republic of China.
Song LeiDepartment of Infectious Disease Control and Prevention, Ningbo Prefectural Center for Disease Control and Prevention, Ningbo, Zhejiang Province, People's Republic of China.
Xiaomin GuDepartment of Infectious Disease Control and Prevention, Ningbo Prefectural Center for Disease Control and Prevention, Ningbo, Zhejiang Province, People's Republic of China.
Xuying LaoDepartment of Infectious Disease Control and Prevention, Ningbo Prefectural Center for Disease Control and Prevention, Ningbo, Zhejiang Province, People's Republic of China.
Xianhao WuDepartment of Infectious Disease Control and Prevention, Ningbo Prefectural Center for Disease Control and Prevention, Ningbo, Zhejiang Province, People's Republic of China.
Weitao YaoDepartment of Infectious Disease Control and Prevention, Ningbo Prefectural Center for Disease Control and Prevention, Ningbo, Zhejiang Province, People's Republic of China.
Yi ChenDepartment of Infectious Disease Control and Prevention, Ningbo Prefectural Center for Disease Control and Prevention, Ningbo, Zhejiang Province, People's Republic of China.
Feng TongDepartment of Infectious Disease Control and Prevention, Ningbo Prefectural Center for Disease Control and Prevention, Ningbo, Zhejiang Province, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To conduct a comprehensive evaluation of the Dengue Fever Surveillance and Early Warning System deployed in Ningbo City during 2023, focusing on its capacity for timely identification and reporting of dengue fever cases, particularly imported cases from endemic regions. Methods: A detailed data of patient clinical features and blood profile trends was collected from clinical records and surveillance reports, focusing on the rapid diagnostic processes and surveillance rigor. This study assessed the effectiveness of the system in identifying and reporting dengue cases and identified the limitations of the existing framework through a basic statistical approach. Results: The system demonstrated timely identification and reporting of dengue fever cases, with a particular emphasis on imported cases. However, several limitations were identified, including the need for more precise monitoring criteria and improved coordination with medical entities. Conclusion: The study underscores the critical role of public health bodies in managing disease outbreaks and advocates for enhanced methodologies to refine epidemic control efforts. The findings contribute to the advancement of early warning mechanisms and the improvement of proactive infectious disease monitoring in metropolitan environments, providing valuable insights for fortifying the Dengue Fever Surveillance and Early Warning System in Ningbo City.

Indexed as

Dengue feverEarly-warningImportedSurveillance

Identifiers

PMID39140008
PMCPMC11321351

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.